Back to company

OLANDER CLINICAL CONSULTING K/S: Financial statements 2018

CVR: 35860177

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,714,996 and a net result of DKK 1,680,844 compared with DKK 1,296,700 the year before. That is an increase of 29.6% compared with the year before. Equity amounted to DKK 700,462. The solvency ratio was 73.9%.

Gross Profit
1,714,996 kr.
Profit/Loss
1,680,844 kr.
Equity
700,462 kr.
Total Assets
948,076 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-1.7 mio.1.7 mio.700 t.-
2017-1.3 mio.1.3 mio.518 t.-
2016-1.5 mio.1.5 mio.699 t.-
2015-817 t.790 t.683 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on OLANDER CLINICAL CONSULTING K/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

OLANDER CLINICAL CONSULTING K/S: The 2017 annual report is outMay 25, 2018

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2017. Gross profit came to DKK 1,323,163, and the net result was DKK 1,296,700.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.